六月 2026
- Home
- Amphastar Pharmaceuticals, Inc.
六月 2026的Amphastar Pharmaceutical...市场份额分析
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
Amphastar Pharmaceuticals, Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- amphastar.com
Amphastar Pharmaceuticals, Inc.收入截至 六月 2026为 500M - 1B
Amphastar Pharmaceuticals, Inc.主要域名产生的收入
3 年中Amphastar Pharmaceuticals, Inc.主要域名的收入
Amphastar Pharmaceuticals, Inc.主要域名的收入
Amphastar Pharmaceuticals, Inc.热门域名的总访问量
了解Amphastar Pharmaceuticals, Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Amphastar Pharmaceuticals, Inc.热门域名的平均访问时长
分析Amphastar Pharmaceuticals, Inc.参与度指标。
过去 3 个月的平均访问时长
子公司明细
Amphastar Pharmaceuticals, Inc.热门域名的平均页面浏览量
了解Amphastar Pharmaceuticals, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Amphastar Pharmaceuticals, Inc. 采用的主要技术
这些是排名前 Amphastar Pharmaceuticals, Inc. 的顶级域名所使用的网站技术(按行业分列)
内容管理系统 (1)
Web Dot Com
转化和分析 (1)
Google Analytics
营销 (1)
Google Marketing Platform
准备好发现优质潜在客户了吗?
借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。
Amphastar Pharmaceuticals, Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Amphastar Pharmaceuticals, Inc. launched Rextovy on Jul 8th '26.The new product, called Rextovy - a 4-milligram naloxone hydrochloride nasal spray manufactured by Amphastar Pharmaceuticals - is now available for direct purchase without a prescription at pharmacies, convenience stores, and online.
七月 9, 2026阅读更多
新闻Amphastar Pharmaceuticals, Inc. is developing over-the-counter nasal spray for opioid overdose on Jun 16th '26.Amphastar Pharmaceuticals gets FDA approval for over-the-counter nasal spray for opioid overdose.
六月 16, 2026阅读更多
新闻Amphastar Pharmaceuticals, Inc. attended event Barclays 27th Annual Global Healthcare Conference on Mar 12th '25.RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12th, 2025, at 10:30 am ET.
三月 5, 2025阅读更多
查看 Amphastar Pharmaceuticals, Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
